$0.93
-0.04 (-4.07%)
Open$0.97
Previous Close$0.97
Day High$0.98
Day Low$0.92
52W High$3.09
52W Low$1.20
Volume—
Avg Volume292.4K
Market Cap188.95M
P/E Ratio2.18
EPS$0.63
SectorPharmaceuticals
Analyst Ratings
Strong Buy
9 analysts
Price Target
+4,185.4% upside
Current
$0.93
$0.93
Target
$39.67
$39.67
$29.46
$39.67 avg
$63.47
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 414.35M | 342.04M | 81.33M |
| Net Income | -39,577,786 | -29,404,001 | 15.27M |
| Profit Margin | -9.6% | -9.1% | 18.8% |
| EBITDA | -22,677,112 | -17,783,767 | 21.57M |
| Free Cash Flow | — | — | 16.42M |
| Rev Growth | +21.1% | +21.1% | -3.5% |
| Debt/Equity | 0.22 | 0.22 | 0.20 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |